Smoking Cessation in Patients Diagnosed with Head and Neck Cancer

Chan, Yvonne; Irish, Jonathan C.; Wood, Stephen; Sommer, Doron D.; Brown, Dale; Gullane, Patrick; O’Sullivan, Brian; Lockwood, Gina

doi:10.2310/7070.2004.00075

Cited by 37 publications

(50 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Efforts are ongoing to improve tobacco cessation efficacy in patients with cancer, including consideration of psychological or behavioral comorbidity, social environment, and diseaserelated variables. [24][25][26][27][28][29][30] These efforts may ultimately result in improved tobacco cessation outcomes, but they will not be realized if patients are not offered tobacco cessation support. Improved education and training may be needed, but improving access to dedicated cessation support is also necessary to improve overall tobacco cessation outcomes.…”

Section: Discussionmentioning

confidence: 99%

Addressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members

Warren

Marshall

Cummings

et al. 2013

JOP

138

155

View full text Add to dashboard Cite

Purpose: Assessing tobacco use and providing cessation support is recommended by the American Society for Clinical Oncology (ASCO). The purpose of this study was to evaluate practice patterns and perceptions of tobacco use and barriers to providing cessation support for patients with cancer. Methods:In 2012, an online survey was sent to 18,502 full ASCO members asking about their practice patterns regarding tobacco assessment, cessation support, perceptions of tobacco use, and barriers to providing cessation support for patients with cancer. Responses from 1,197 ASCO members are reported.

show abstract

Section: Discussionmentioning

confidence: 99%

Addressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members

Warren

Marshall

Cummings

et al. 2013

JOP

138

155

View full text Add to dashboard Cite

show abstract

“…In particular, alcohol use and smoking are two of the strongest HNC risk factors [31], and many individuals continue their use during and after diagnosis and treatment [32][33][34][35]. Individuals who continue to smoke and use alcohol after diagnosis and treatment are more likely to experience tumour recurrence and second primary malignancies [35], as well having lower quality of life, poorer functional abilities and higher levels of pain [32][33][34]. All of these could also influence patterns of return to work, and thus the unavailability of information on tobacco and alcohol use is a limitation.…”

Section: Strengths and Limitationsmentioning

confidence: 99%

Long-term workforce participation patterns following head and neck cancer

et al. 2014

View full text Add to dashboard Cite

“…12 Additional work has shown that the relative risk of mortality among those who quit is 0.6 compared with those who continue to smoke. 13 Prior studies 7,14 examining patients with cancer found that smokers were more likely to successfully quit after diagnosis if they reported more cessation attempts in the prior year. While it is possible that many smokers who ultimately develop HNSCC have made attempts at tobacco cessation, patterns of prediagnostic tobacco cessation attempts are poorly studied to date.…”

mentioning

confidence: 99%

“…This is especially needed given the high number of smokers who continue to smoke after a diagnosis of HNSCC. 7 To better understand this group of smokers, we examined a cohort of cigarette smokers presenting with HNSCC to determine the frequency with which they attempted to quit over their lifetime, the symptoms they experienced during quit attempts, and which symptoms were most associated with their attempts at cessation.…”

mentioning

confidence: 99%

“…[2][3][4] For example, when considering smokers with HNSCC, 54% to 69% demonstrate cessation for some period around the time of diagnosis, while the remainder continue smoking. [5][6][7] When considering smokers developing lung and/or head and neck cancer, a recent systematic review revealed that, while there is variability between studies, 9% to 55% of those developing these cancers will persistently smoke after diagnosis or relapse after temporarily quitting. Thus, patients who continue to smoke and those that relapse make up a significant fraction of smokers with HNSCC.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma

Khariwala

Hatsukami

Stepanov

et al. 2018

JAMA Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

IMPORTANCE Among smokers with head and neck squamous cell carcinoma (HNSCC), there is ample evidence regarding the benefits of smoking cessation prior to treatment. Prior data indicates that increased attempts at cessation result in higher likelihood of cessation after diagnosis but the prediagnostic patterns of smoking cessation attempts among those smokers developing HNSCC has not been characterized. Data of this kind may direct cessation efforts toward increased efficacy.OBJECTIVE To determine the frequency and character of tobacco cessation attempts and symptoms experienced prior to development of HNSCC, as well as to determine the correlation of these symptoms with number of cessation attempts and maximum quit days. DESIGN, SETTING, AND PARTICIPANTSCross-sectional study including 123 active smokers with HNSCC recruited from a tertiary medical center at an academic institution from February 2014 to May 2017.EXPOSURES All included patients were active cigarette smokers prior to developing HNSCC. MAIN OUTCOMES AND MEASURESPatients provided data indicating intensity of smoking, duration, number of cessation attempts, maximum number of days during which they successfully ceased smoking, and symptoms during cessation attempts. Principal component analysis was used to identify clustering of symptoms. Overall, 108 patients (88%) had made at least 1 prior attempt at cessation, and the mean number of lifetime cessation attempts was 6.6. Symptoms of cravings, restlessness, irritability, and anxiety were reported most frequently. Symptoms were clustered into 2 component groups: component group 1 (C1; increased appetite, cravings, depression) and component group 2 (C2; restlessness, irritability, insomnia, anxiety, and difficulty concentrating). Component group 2 correlated with quit attempts (Spearman correlation, 0.268 [95% CI, 0.07 to 0.45]), and C1 and C2 were not correlated with maximum quit days. Cessation attempts and maximum quit days positively correlated with each other.CONCLUSIONS AND RELEVANCE Our analysis shows that symptoms during cessation attempts tend to cluster and that most patients made 1 or more cessation attempts. Many patients successfully ceased before restarting. Our data suggest that patients experiencing C2 symptoms make more quit attempts; C1 symptoms may be more difficult to overcome because they are associated with fewer quit attempts. Future work will address whether amelioration of these symptoms may help smoking cessation among smokers with HNSCC.

show abstract

Smoking Cessation in Patients Diagnosed with Head and Neck Cancer

Cited by 37 publications

References 0 publications

Addressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members

Addressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members

Long-term workforce participation patterns following head and neck cancer

Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma

Contact Info

Product

Resources

About